What is the new relax medicine?: An overview of recent breakthroughs
•
5 min read
In January 2025, the FDA approved Journavx (suzetrigine), the first new class of pain reliever in over two decades, which also has a relaxing effect by modulating pain signals. This and other recent advancements are reshaping the answer to the question: **What is the new relax medicine?**
